These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7297020)

  • 1. Beta-blocking effect of single oral doses of carteolol.
    Stoll RW; Cavanaugh JH; MacLeod CM
    Clin Pharmacol Ther; 1981 Nov; 30(5):605-10. PubMed ID: 7297020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration-effect and time-effect relationships of carteolol.
    Ishizaki T; Ohnishi A; Sasaki T; Chiba K; Suganuma T; Kushida K
    Eur J Clin Pharmacol; 1983; 25(6):749-57. PubMed ID: 6141053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
    Kober G; Veidt J; Mikludy R; Kaltenbach M
    Arzneimittelforschung; 1983; 33(2a):313-7. PubMed ID: 6682323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of carteolol on silent myocardial ischemia, variability in heart rate, and the pain-modulating system.
    Takase B; Hikita H; Uehata A; Satomura K; Kurita A; Nakamura H
    Am Heart J; 1997 Nov; 134(5 Pt 1):945-54. PubMed ID: 9398108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long use of a beta-blocker, carteolol, on exercise hemodynamics in hypertensives.
    Katori R; Tashi M; Ohno M; Oogai T; Morishita M; Morii S
    Jpn Circ J; 1985 Jan; 49(1):52-60. PubMed ID: 3968862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent antihypertensive effect of carteolol--a beta-adrenoceptor antagonist with partial agonist activity.
    Giles TD; Sander GE; Kaneish A; Quiroz AC
    Clin Pharmacol Ther; 1984 Mar; 35(3):301-6. PubMed ID: 6697637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics].
    Hugues FC; Le Jeunne C; Munera Y; Dufier JL
    J Fr Ophtalmol; 1987; 10(8-9):485-90. PubMed ID: 2892874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacodynamics of carteolol].
    Odenthal KP
    Arzneimittelforschung; 1983; 33(2a):281-5. PubMed ID: 6132609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose difference in beta-adrenergic blockers with intrinsic sympathomimetic action to block beta-adrenoceptors and induce sympathomimetic action.
    Takayanagi I; Ogishima M; Koike K; Hisayama T; Hayashida M; Fujii M
    Gen Pharmacol; 1989; 20(4):417-9. PubMed ID: 2568966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic studies at rest and under stress in patients with coronary heart disease after administration of carteolol].
    Saborowski F; Dundalek E; Griebenow R; Sy M
    Arzneimittelforschung; 1983; 33(2a):310-2. PubMed ID: 6682322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single dose of three different ophthalmic beta-blockers antagonizes the chronotropic effect of isoproterenol in healthy volunteers.
    Berlin I; Marcel P; Uzzan B; Millon D; Le Hoang P; Puech AJ
    Clin Pharmacol Ther; 1987 Jun; 41(6):622-6. PubMed ID: 2884059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the cardiodepressant action of a beta-blocking agent carteolol in heart-lung preparation of the dog.
    Ono H; O'Hara N
    Jpn Circ J; 1984 Sep; 48(9):1030-44. PubMed ID: 6481940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of in vivo partial beta 1/beta 2-agonist activity: a dose-ranging study with carteolol.
    Wheeldon NM; McDevitt DG; Lipworth BJ
    Br J Clin Pharmacol; 1992 Apr; 33(4):411-6. PubMed ID: 1349493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative long-term vasoactive effects of atenolol and carteolol on the properties of the small and large arteries of the upper extremities in human essential hypertension.
    Merli IP; Levenson J; Filitti V; Simon A
    Clin Pharmacol Ther; 1989 Dec; 46(6):686-92. PubMed ID: 2689046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inotropic and chronotropic responses of isolated canine atrium to 5-(3-tert.-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (carteolol).
    Chiba S
    Arzneimittelforschung; 1979; 29(6):895-7. PubMed ID: 582780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory blood pressure and heart rate during once-daily, randomized, crossover administration of carteolol and atenolol.
    Saito K; Furuta Y; Sano H; Yokoyama M; Fukuzaki H
    Clin Ther; 1994; 16(2):181-90. PubMed ID: 8062314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.
    Brazier DJ; Smith SE
    Br J Ophthalmol; 1988 Feb; 72(2):101-3. PubMed ID: 3349009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of carteolol, indenolol and metoprolol on the thyroid hormone of hyperthyroid patients.
    Yamamoto M; Sakurada T; Yoshida K; Kaise K; Kaise N; Fukazawa H; Suzuki M; Nomura T; Itagaki Y; Saito S
    Tohoku J Exp Med; 1985 Aug; 146(4):385-90. PubMed ID: 2866611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral befunolol on heart rate and systolic blood pressure during submaximal exercise in man.
    Miki N; Furusho Y; Itaya K; Midorikawa K; Kumagai E; Terasawa M; Ihara S; Matoba T; Toshima H
    Jpn Circ J; 1980 Oct; 44(10):783-93. PubMed ID: 6107392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 2-adrenoceptor-mediated intrinsic sympathomimetic activity of carteolol: an in vivo study.
    Bruck H; Poller U; Lüssenhop H; Pönicke K; Temme T; Heusch G; Philipp T; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):361-8. PubMed ID: 15526107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.